These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7644531)
21. Neural overexcitation and implication of NMDA and AMPA receptors in a mouse model of temporal lobe epilepsy implying zinc chelation. Domínguez MI; Blasco-Ibáñez JM; Crespo C; Nacher J; Marqués-Marí AI; Martínez-Guijarro FJ Epilepsia; 2006 May; 47(5):887-99. PubMed ID: 16686654 [TBL] [Abstract][Full Text] [Related]
22. D-aspartate and NMDA, but not L-aspartate, block AMPA receptors in rat hippocampal neurons. Gong XQ; Frandsen A; Lu WY; Wan Y; Zabek RL; Pickering DS; Bai D Br J Pharmacol; 2005 Jun; 145(4):449-59. PubMed ID: 15806114 [TBL] [Abstract][Full Text] [Related]
23. High efficiency reconstitution of a phencyclidine/MK-801 receptor binding site solubilized from rat forebrain membranes. Haring R; Pellegrini-Giampietro DE; Zukin SR; Zukin RS; Scheideler MA Mol Pharmacol; 1991 Nov; 40(5):666-73. PubMed ID: 1658603 [TBL] [Abstract][Full Text] [Related]
24. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. Kenny PJ; Gasparini F; Markou A J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481 [TBL] [Abstract][Full Text] [Related]
25. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain. Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317 [TBL] [Abstract][Full Text] [Related]
26. Structural conservation of ion conduction pathways in K channels and glutamate receptors. Wood MW; VanDongen HM; VanDongen AM Proc Natl Acad Sci U S A; 1995 May; 92(11):4882-6. PubMed ID: 7761417 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-affinity relationships of 1,3, 5-alkylsubstituted cyclohexylamines binding at NMDA receptor PCP site. Jirgensons A; Kauss V; Kalvinsh I; Gold MR; Danysz W; Parsons CG; Quack G Eur J Med Chem; 2000 Jun; 35(6):555-65. PubMed ID: 10906408 [TBL] [Abstract][Full Text] [Related]
28. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes. Coughenour LL; Cordon JJ J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267 [TBL] [Abstract][Full Text] [Related]
29. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus. Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131 [TBL] [Abstract][Full Text] [Related]
30. Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex. Javitt DC; Frusciante MJ; Zukin SR J Pharmacol Exp Ther; 1994 Aug; 270(2):604-13. PubMed ID: 7915316 [TBL] [Abstract][Full Text] [Related]
31. Phencyclidine inhibits epinephrine-stimulated platelet aggregation independently of high affinity N-methyl-D-aspartate (NMDA)-type glutamatereceptors. Raulli RE; Jackson B; Tandon N; Mattson M; Rice K; Jamieson GA Biochim Biophys Acta; 1994 Nov; 1224(2):175-80. PubMed ID: 7981230 [TBL] [Abstract][Full Text] [Related]
33. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology. Monaghan DT; Larsen H J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271 [TBL] [Abstract][Full Text] [Related]
34. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. Urushitani M; Nakamizo T; Inoue R; Sawada H; Kihara T; Honda K; Akaike A; Shimohama S J Neurosci Res; 2001 Mar; 63(5):377-87. PubMed ID: 11223912 [TBL] [Abstract][Full Text] [Related]
35. Different structural requirements for functional ion pore transplantation suggest different gating mechanisms of NMDA and kainate receptors. Villmann C; Hoffmann J; Werner M; Kott S; Strutz-Seebohm N; Nilsson T; Hollmann M J Neurochem; 2008 Oct; 107(2):453-65. PubMed ID: 18710418 [TBL] [Abstract][Full Text] [Related]
36. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex. Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125 [TBL] [Abstract][Full Text] [Related]
37. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Olmos G; DeGregorio-Rocasolano N; Paz Regalado M; Gasull T; Assumpció Boronat M; Trullas R; Villarroel A; Lerma J; García-Sevilla JA Br J Pharmacol; 1999 Jul; 127(6):1317-26. PubMed ID: 10455281 [TBL] [Abstract][Full Text] [Related]
38. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists. French ED; Mura A; Wang T Synapse; 1993 Feb; 13(2):108-16. PubMed ID: 8446919 [TBL] [Abstract][Full Text] [Related]
39. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission. Frizelle PA; Chen PE; Wyllie DJ Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008 [TBL] [Abstract][Full Text] [Related]